Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021

Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data

Volz, E., Mishra, S., Chand, M., Barrett, J. C., Johnson, R., Geidelberg, L., Hinsley, W. R., Laydon, D. J., Dabrera, G., O’Toole, Á., et al. (2021) · doi:10.1101/2020.12.30.20249034 · Cited by 1,611

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

The COVID-19 Genomics UK (COG-UK) consortium, Volz, E., Mishra, S., Chand, M., Barrett, J. C., Johnson, R., Geidelberg, L., Hinsley, W. R., Laydon, D. J., Dabrera, G., et al. (2021) · Nature · doi:10.1038/s41586-021-03470-x · Cited by 1,611

Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021

Galloway, S. E., Paul, P., MacCannell, D., Johansson, M. A., Brooks, J. T., MacNeil, A., Slayton, R. B., Tong, S., Silk, B. J., Armstrong, G. L., et al. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7003e2 · Cited by 609

Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70

Kemp, S. A., Meng, B., Ferriera, I. A., Datir, R., Harvey, W. T., Papa, G., Lytras, S., Collier, D. A., Mohamed, A., Gallo, G., et al. (2020) · doi:10.1101/2020.12.14.422555 · Cited by 252

S-Variant SARS-CoV-2 Lineage B1.1.7 Is Associated With Significantly Higher Viral Load in Samples Tested by TaqPath Polymerase Chain Reaction

Kidd, M., Richter, A., Best, A., Cumley, N., Mirza, J., Percival, B., Mayhew, M., Megram, O., Ashford, F., White, T., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab082 · Cited by 237

Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69–V70, France, August to December 2020

Bal, A., Destras, G., Gaymard, A., Stefic, K., Marlet, J., Eymieux, S., Regue, H., Semanas, Q., d’Aubarede, C., Billaud, G., et al. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.3.2100008 · Cited by 212

Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2

O'Toole, Á., Hill, V., Pybus, O. G., Watts, A., Bogoch, I. I., Khan, K., Messina, J. P., The COVID-19 Genomics UK (COG-UK) consortium, Network for Genomic Surveillance in South Africa (NGS-SA), Brazil-UK CADDE Genomic Network, et al. (2021) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16661.1 · Cited by 192

Screening of the H69 and V70 deletions in the SARS-CoV-2 spike protein with a RT-PCR diagnosis assay reveals low prevalence in Lyon, FrancePreprint

Bal, A., Destras, G., Gaymard, A., et al. (2020) · medRxiv · doi:10.1101/2020.11.10.20228528 · Cited by 147

S-variant SARS-CoV-2 is associated with significantly higher viral loads in samples tested by ThermoFisher TaqPath RT-PCRPreprint

Kidd, M., Richter, A., Best, A., et al. (2020) · medRxiv · doi:10.1101/2020.12.24.20248834 · Cited by 36

High throughput diagnostics and dynamic risk assessment of SARS-CoV-2 variants of concern

Gravagnuolo, A. M., Faqih, L., Cronshaw, C., Wynn, J., Burglin, L., Klapper, P. E., & Wigglesworth, M. J. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103540 · Cited by 30

Epidemiological Investigation of New SARS-CoV-2 Variant of Concern 202012/01 in EnglandPreprint

Gravagnuolo, A. M., Faqih, L., Cronshaw, C., et al. (2021) · medRxiv · doi:10.1101/2021.01.14.21249386 · Cited by 10

The biological and clinical significance of emerging SARS-CoV-2 variants

Tao, K., Tzou, P. L., Nouhin, J., Gupta, R. K., de Oliveira, T., Kosakovsky Pond, S. L., Fera, D., & Shafer, R. W. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00408-x · Cited by 1,009

Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States

Washington, N. L., Gangavarapu, K., Zeller, M., Bolze, A., Cirulli, E. T., Barrett, K. M. S., Larsen, B. B., Anderson, C., White, S., Cassens, T., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.052 · Cited by 324

Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants

Welch, N. L., Zhu, M., Hua, C., Weller, J., Mirhashemi, M. E., Nguyen, T. G., Mantena, S., Bauer, M. R., Shaw, B. M., Ackerman, C. M., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01734-1 · Cited by 310

Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021

Funk, T., Pharris, A., Spiteri, G., Bundle, N., Melidou, A., Carr, M. J., González, G., Leon, A. A. G., Crispie, F., O’Connor, L., et al. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.16.2100348 · Cited by 246

Simplified Cas13-based assays for the fast identification of SARS-CoV-2 and its variants

Arizti-Sanz, J., Bradley, A. Y., Zhang, Y. B., Boehm, C. K., Freije, C. A., Grunberg, M. E., Kosoko-Thoroddsen, T.-S. F., Welch, N. L., Pillai, P. P., Mantena, S., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00889-z · Cited by 231

Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2

Vogels, C. B. F., Breban, M. I., Ott, I. M., Alpert, T., Petrone, M. E., Watkins, A. E., Kalinich, C. C., Earnest, R., Rothman, J. E., de Jesus, J. G., et al. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001236 · Cited by 225

Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States

Alpert, T., Brito, A. F., Lasek‐Nesselquist, E., Rothman, J. E., Valesano, A. L., MacKay, M. J., Petrone, M. E., Breban, M. I., Watkins, A. E., Vogels, C. B. F., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.061 · Cited by 122

Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022

Eggink, D., Andeweg, S. P., Vennema, H., van Maarseveen, N. M., Vermaas, K., Vlaemynck, B., Schepers, R., van Gageldonk-Lafeber, A. B., van den Hof, S., Reusken, C. B. E. M., et al. (2022) · Eurosurveillance · doi:10.2807/1560-7917.es.2022.27.4.2101196 · Cited by 89

Progress and challenges in virus genomic epidemiology

Hill, V., Ruis, C., Bajaj, S., Pybus, O. G., & Kraemer, M. U. G. (2021) · Trends in Parasitology · doi:10.1016/j.pt.2021.08.007 · Cited by 88

Mutation-Specific SARS-CoV-2 PCR Screen: Rapid and Accurate Detection of Variants of Concern and the Identification of a Newly Emerging Variant with Spike L452R Mutation

Wang, H., Jean, S., Eltringham, R., Madison, J., Snyder, P. J., Tu, H., Jones, D. M., & Leber, A. L. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00926-21 · Cited by 72

One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages

Gónzález‐Candelas, F., Shaw, M., Phan, T. G., Kulkarni‐Kale, U., Paraskevis, D. N., Luciani, F., Kimura, H., & Sironi, M. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104869 · Cited by 65

Physicochemical effect of the N501Y, E484K/Q, K417N/T, L452R and T478K mutations on the SARS-CoV-2 spike protein RBD and its influence on agent fitness and on attributes developed by emerging variants of concern

Pondé, R. A. D. A. (2022) · Virology · doi:10.1016/j.virol.2022.05.003 · Cited by 53

Diagnostics and analysis of SARS-CoV-2: current status, recent advances, challenges and perspectives

Dong, T., Wang, M., Liu, J., Ma, P., Pang, S., Liu, W., & Liu, A. (2023) · Chemical Science · doi:10.1039/d2sc06665c · Cited by 50

Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines

Zinatizadeh, M. R., Zarandi, P. K., Zinatizadeh, M., Yousefi, M. H., Amani, J., & Rezaei, N. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112527 · Cited by 51

Spike protein of SARS-CoV-2 variants: a brief review and practical implications

Candido, K. L., Eich, C. R., de Fariña, L. O., Kadowaki, M. K., Silva, J. L. D. C., Maller, A., & Simão, R. D. C. G. (2022) · Brazilian Journal of Microbiology · doi:10.1007/s42770-022-00743-z · Cited by 46

Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences

Hoteit, R., & Yassine, H. M. (2022) · Vaccines · doi:10.3390/vaccines10060919 · Cited by 47

A SARS-CoV-2 mutant from B.1.258 lineage with ∆H69/∆V70 deletion in the Spike protein circulating in Central Europe in the fall 2020

Brejová, B., Boršová, K., Hodorová, V., Čabanová, V., Reizigová, L., Paul, E. D., Čekan, P., Klempa, B., Nosek, J., & Vinař, T. (2021) · Virus Genes · doi:10.1007/s11262-021-01866-5 · Cited by 47

Public health implications of SARS-CoV-2 variants of concern: a rapid scoping review

Somerville, M., Curran, J., Dol, J., Boulos, L., Saxinger, L. M., Doroshenko, A., Hastings, S. E., Reynolds, B., Gallant, A. J., Shin, H. D., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-055781 · Cited by 37

Comparative Effectiveness of Coronavirus Vaccine in Preventing Breakthrough Infections among Vaccinated Persons Infected with Delta and Alpha Variants

Kislaya, I., Rodrigues, E. F., Borges, V., Gomes, J. P., Sousa, C., Almeida, J. P., Peralta‐Santos, A., Nunes, B., & Group2, P.-C.-1. (2021) · Emerging infectious diseases · doi:10.3201/eid2802.211789 · Cited by 36

SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells

Nchioua, R., Schundner, A., Kmieć, D., Bozzo, C. P., Zech, F., Koepke, L., Graf, A., Krebs, S., Blum, H., Frick, M., et al. (2022) · Journal of Virology · doi:10.1128/jvi.00594-22 · Cited by 38

Rapid Spread of the SARS-CoV-2 Variant of Concern 202012/01 in Southern Italy (December 2020–March 2021)

Loconsole, D., Centrone, F., Morcavallo, C., Campanella, S., Sallustio, A., Accogli, M., Fortunato, F., Parisi, A., & Chironna, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18094766 · Cited by 33

Update of Guidelines for Laboratory Diagnosis of COVID-19 in Korea

Hong, K. H., Kim, G. J., Roh, K. H., Sung, H., Lee, J., Kim, S. Y., Kim, T. S., Park, J. S., Huh, H. J., Park, Y., et al. (2022) · Annals of Laboratory Medicine · doi:10.3343/alm.2022.42.4.391 · Cited by 32

The Alpha Variant (B.1.1.7) of SARS-CoV-2 Failed to Become Dominant in Mexico

Zárate, S., Taboada, B., Muñoz‐Medina, J. E., Iša, P., Sánchez‐Flores, A., Boukadida, C., Herrera‐Estrella, A., Mojica, N. S., Rosales-Rivera, M., Gómez‐Gil, B., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02240-21 · Cited by 31

Evaluation of two RT-PCR screening assays for identifying SARS-CoV-2 variants

Migueres, M., Lhomme, S., Trémeaux, P., Dimeglio, C., Ranger, N., Latour, J., Dubois, M., Nicot, F., Miédougé, M., Mansuy, J., et al. (2021) · Journal of Clinical Virology · doi:10.1016/j.jcv.2021.104969 · Cited by 30

The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2

Fang, L., Xu, J., Zhao, Y., Fan, J., Shen, J., Liu, W., & Cao, G. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1228128 · Cited by 26

Comparison of different sequencing techniques for identification of SARS-CoV-2 variants of concern with multiplex real-time PCR

Ranasinghe, D., Jayadas, T. T. P., Jayathilaka, D., Jeewandara, C., Dissanayake, O., Guruge, D., Ariyaratne, D., Gunasinghe, D. N., Gomes, L., Wijesinghe, A., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265220 · Cited by 21

Impact of stringent non-pharmaceutical interventions applied during the second and third COVID-19 epidemic waves in Portugal, 9 November 2020 to 10 February 2021: an ecological study

Torres, A. R., Rodrigues, A. P., Sousa‐Uva, M., Kislaya, I., Silva, S. P., Antunes, L., Dias, C. M., & Nunes, B. (2022) · Eurosurveillance · doi:10.2807/1560-7917.es.2022.27.23.2100497 · Cited by 20

Altered subgenomic RNA abundance provides unique insight into SARS-CoV-2 B.1.1.7/Alpha variant infections

Parker, M. D., Stewart, H., Shehata, O. M., Lindsey, B. B., Shah, D. R., Hsu, S. N., Keeley, A. J., Partridge, D. G., Leary, S., Cope, A., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03565-9 · Cited by 49

Distribution of SARS-CoV-2 Variants in a Large Integrated Health Care System — California, March–July 2021

Malden, D. E., Bruxvoort, K. J., Tseng, H. F., Ackerson, B. K., Choi, S. K., Florea, A., Tubert, J. E., Takhar, H. S., Aragones, M., Hong, V. X., et al. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7040a4 · Cited by 19

Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants

Blanquart, F., Hozé, N., Cowling, B. J., Débarre, F., & Cauchemez, S. (2022) · eLife · doi:10.7554/elife.75791 · Cited by 15

New SARS-CoV-2 Omicron variant — clinical picture, treatment, prevention (literature review)

Vechorko, V. I., Валерьевич, А. О., & Зимин, А. А. (2022) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2022-3228 · Cited by 17

The emerging pandemic recent: SARS-CoV-2

Cha, Y., Jung, W., Seo, M., & Rahmati, M. (2023) · Life Cycle · doi:10.54724/lc.2023.e2 · Cited by 16

Rapid Automated Screening for SARS-CoV-2 B.1.617 Lineage Variants (Delta/Kappa) through a Versatile Toolset of qPCR-Based SNP Detection

Nörz, D. S., Grunwald, M., Tang, H. T., Olearo, F., Günther, T., Robitaille, A., Fischer, N., Grundhoff, A. T., Aepfelbacher, M., Pfefferle, S., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11101818 · Cited by 16

An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2

Hassan, S. S., Kodakandla, V., Redwan, E. M. M. M., Lundstrom, K. H., Choudhury, P. P., El‐Aziz, T. M. A., Takayama, K., Kandimalla, R. J. L., Lal, A., Serrano‐Aroca, Á., et al. (2022) · PeerJ · doi:10.7717/peerj.13136 · Cited by 16

Higher risk of SARS-CoV-2 Omicron BA.4/5 infection than of BA.2 infection after previous BA.1 infection, the Netherlands, 2 May to 24 July 2022

Andeweg, S. P., de Gier, B., Vennema, H., Walle, I. V., van Maarseveen, N. M., Kusters, N. E., de Melker, H. E., Hahné, S. J. M., van den Hof, S., Eggink, D., et al. (2023) · Eurosurveillance · doi:10.2807/1560-7917.es.2023.28.7.2200724 · Cited by 14

Delta variant and mRNA Covid-19 vaccines effectiveness: higher odds of vaccine infection breakthroughsPreprint

Kislaya, I., Rodrigues, E. F., Borges, V., Gomes, J. P., Sousa, C., Almeida, J. P., Peralta‐Santos, A., & Nunes, B. (2021) · medRxiv · doi:10.1101/2021.08.14.21262020 · Cited by 13

Spatiotemporal Dynamics of COVID-19 Infections in Mainland Portugal

Silva, M., Betco, I., Capinha, C., Roquette, R., Viana, C. M., & Rocha, J. (2022) · Sustainability · doi:10.3390/su141610370 · Cited by 12

Patterns and drivers of excess mortality during the COVID-19 pandemic in 13 Western European countries

Galmiche, S., Coustaury, C., Charniga, K., Grant, R., Cauchemez, S., Fontanet, A. L., The Western European Covid-19 Excess Mortality Working Group, Autran, B., Barnbrook, M., Barros, H., et al. (2024) · BMC Global and Public Health · doi:10.1186/s44263-024-00103-z · Cited by 15

Targeted Sanger sequencing to recover key mutations in SARS-CoV-2 variant genome assemblies produced by next-generation sequencing

Singh, L., San, J. E., Tegally, H., Brzoska, P. M., Anyaneji, U. J., Wilkinson, E., Clark, L. V., Giandhari, J., Pillay, S., Lessells, R. J., et al. (2022) · Microbial Genomics · doi:10.1099/mgen.0.000774 · Cited by 7

Precision health diagnostic and surveillance network uses S gene target failure (SGTF) combined with sequencing technologies to track emerging SARS‐CoV‐2 variants

Guerrero-Preston, R. E., Rivera‐Amill, V., Caraballo, K., Rodríguez‐Torres, S., Purcell‐Wiltz, A., García, A. A., Torres, R. S., Zamunér, F. T., Zanettini, C., MacKay, M. J., et al. (2022) · Immunity Inflammation and Disease · doi:10.1002/iid3.634 · Cited by 8

Developing Biosensors for SARS-CoV-2 Wastewater-Based Epidemiology: A Systematic Review of Trends, Limitations and Future Perspectives

Azubuike, C. C., Couceiro, F., Robson, S. C., Piccinni, M. Z., Watts, J. E. M., Williams, J., Callaghan, A. J., & Howard, T. P. (2022) · Sustainability · doi:10.3390/su142416761 · Cited by 8

Viral loads observed under competing strain dynamicsPreprint

Hay, J. A., Kennedy‐Shaffer, L., & Mina, M. J. (2021) · medRxiv · doi:10.1101/2021.07.27.21261224 · Cited by 8

Identifying SARS-CoV-2 Variants of Concern through Saliva-Based RT-qPCR by Targeting Recurrent Mutation Sites

Ham, R. E., Smothers, A. R., Che, R., Sell, K. J., Peng, C. A., & Dean, D. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00797-22 · Cited by 7

Comparative complete scheme and booster effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infections with SARS-CoV-2 Omicron (BA.1) and Delta (B.1.617.2) variantsPreprint

Kislaya, I., Peralta‐Santos, A., Borges, V., Vieira, L., Sousa, C., Ferreira, B., Pelerito, A., Gomes, J. P., Leite, P. P., & Nunes, B. (2022) · medRxiv · doi:10.1101/2022.01.31.22270200 · Cited by 7

Assessment of the Effective Sensitivity of SARS-CoV-2 Sample Pooling Based on a Large-Scale Screening Experience: Retrospective Analysis

Cabrera, J. J., Larrañaga, A., Martínez, J. M., Pérez‐Castro, S., Cao, S. R., Daviña‐Núñez, C., del Campo-Pérez, V., Parrondo, C. D., Luque, S. S., Alonso, E. G., et al. (2024) · JMIR Public Health and Surveillance · doi:10.2196/54503 · Cited by 6

Setting-Up a Rapid SARS-CoV-2 Genome Assessment by Next-Generation Sequencing in an Academic Hospital Center (LPCE, Louis Pasteur Hospital, Nice, France)

Hofman, P. M., Bordone, O., Chamorey, E., Benzaquen, J., Schiappa, R., Lespinet‐Fabre, V., Lantéri, E., Brest, P., Mograbi, B., Maniel, C., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.730577 · Cited by 7

Combined Use of RT-qPCR and NGS for Identification and Surveillance of SARS-CoV-2 Variants of Concern in Residual Clinical Laboratory Samples in Miami-Dade County, Florida

Carattini, Y., Griswold, A. J., Williams, S. L., Valiathan, R., Zhou, Y., Shukla, B. S., Abbo, L. M., Parra, K., Jordà, M., Nimer, S. D., et al. (2023) · Viruses · doi:10.3390/v15030593 · Cited by 6

Current molecular diagnostics assays for SARS-CoV-2 and emerging variants

Banks, J. M., Capistrano, K. J., Thakkar, P., Ranade, H., Soni, V., Datta, M., & Naqvi, A. R. (2022) · Methods in microbiology · doi:10.1016/bs.mim.2021.10.003 · Cited by 6

Proof of concept of the potential of a machine learning algorithm to extract new information from conventional SARS-CoV-2 rRT-PCR results

Cabrera, J. J., Larrañaga, A., Pérez‐Castro, S., Martínez, J. M., Lamas, L. M., Daviña‐Núñez, C., del Campo-Pérez, V., Luque, S. S., Regueiro, B. J., & Fresco, J. P. (2023) · Scientific Reports · doi:10.1038/s41598-023-34882-6 · Cited by 7

Increased Residential Clustering of COVID-19 Cases Associated With SARS-CoV-2 Variant of Concern B.1.1.7

Flannagan, J., Twohig, K. A., Carter, E., Chudasama, D. Y., Lamagni, T. L., & Dabrera, G. (2022) · Epidemiology · doi:10.1097/ede.0000000000001497 · Cited by 5

Accuracy of Allplex SARS-CoV-2 Assay Amplification Curve Analysis for the detection of SARS-CoV-2 Variant Alpha

Čretnik, T. Ž., Retelj, M., Janežič, S., Mahnič, A., Tesovnik, T., Šket, R., Bizjan, B. J., Jeverica, S., Ravnik, M., Rak, M., et al. (2022) · Future Microbiology · doi:10.2217/fmb-2021-0288 · Cited by 4

High quality of SARS-CoV-2 molecular diagnostics in a diverse laboratory landscape through supported benchmark testing and External Quality Assessment

Sluimer, J., van den Akker, W. M. R., Goderski, G., Swart, A., van der Veer, B., Cremer, J., Chung, N. H., Molenkamp, R., Voermans, J. J. C., Guldemeester, J., et al. (2024) · Scientific Reports · doi:10.1038/s41598-023-50912-9 · Cited by 4

Estimating the effect of COVID-19 vaccination and prior infection on cycle threshold values as a proxy of SARS-CoV-2 viral load

Andeweg, S. P., van de Kassteele, J., Wang, X., van Maarseveen, N. M., Vlaemynck, B., Bos, S., Vennema, H., Presser, L., Cai, J., Knol, M. J., et al. (2024) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2024.107362 · Cited by 3

S-Gene Target Failure as an Effective Tool for Tracking the Emergence of Dominant SARS-CoV-2 Variants in Switzerland and Liechtenstein, Including Alpha, Delta, and Omicron BA.1, BA.2, and BA.4/BA.5

Hilti, D., Wehrli, F., Berchtold, S., Bigler, S., Bodmer, T., Seth-Smith, H. M. B., Roloff, T. C., Kohler, P. P., Kahlert, C. R., Kaiser, L., et al. (2024) · Microorganisms · doi:10.3390/microorganisms12020321 · Cited by 3

Comparative Diagnostic Performance of a Novel Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP) Kit for the Rapid Detection of SARS-CoV-2

Domnich, A., Orsi, A., Panatto, D., Pace, V. D., Ricucci, V., Caligiuri, P., Guarona, G., Chessa, V., Ferone, D., Boccotti, S., et al. (2021) · Pathogens · doi:10.3390/pathogens10121629 · Cited by 3

A Stochastic Model of an Early Warning System for Detecting Anomalous Incidence Values of COVID-19

Duarte, A. F., Soares, A., Pereira, M. J. V. D. C. R., Peralta‐Santos, A., Leite, P. P., & Azevedo, L. (2023) · Mathematical Geosciences · doi:10.1007/s11004-023-10096-4 · Cited by 2

Unraveling the hurdles of a large COVID-19 epidemiological investigation by viral genomics

Sá, R., Isidro, J., Borges, V., Duarte, S., Vieira, L., Gomes, J. P., Tedim, S., Matias, J., & Leite, A. (2022) · Journal of Infection · doi:10.1016/j.jinf.2022.05.013 · Cited by 2

SARS-CoV-2 variants of concern remain dependent on IFITM2 for efficient replication in human lung cellsPreprint

Nchioua, R., Schundner, A., Kmieć, D., Bozzo, C. P., Zech, F., Koepke, L., Graf, A., Krebs, S., Blum, H., Frick, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.06.471527 · Cited by 2

Analytical performance of rapid nucleic acid detection assays and routine RT-qPCR assays for detection of SARS-CoV-2 in Shanghai, China in 2022

Jiang, M., Chen, W., Chen, Y., Chen, J., Zhang, Y., Hongmei, Y., Li, Y., & Liu, W. (2022) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2022.115860 · Cited by 1

SARS-CoV-2 VOC 202012/01(B.1.1.7) Variant: Is it More Dangerous ?

Aslanlar, D. A., Aydemir, Ö., Kunt, M., Koç, E., & Koc, M. (2023) · Selçuk Tıp Dergisi · doi:10.30733/std.2023.01606 · Cited by 1

A straightforward one-step strategy for SARS-CoV-2 diagnosis and screening of variants of concern: a multicentre study

Fontana‐Maurell, M., Motta, F. C., Arruda, M. B., Cardoso, P., Ribeiro, M., de Andrade, E. F., de Godoy, D. T., Costa, E. M., Rocha, D., Siqueira, M. A. M., et al. (2023) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760220202 · Cited by 1

Effect of Covid-19 Vaccines Against Delta Variant. A Review Article

Raslan, M. A., Eslam, M. S., Sara, A. R., & Sabri, N. A. (2022) · Acta Scientific Pharmaceutical Sciences · doi:10.31080/asps.2022.06.0849 · Cited by 1

CAN A MACHINE LEARNING ALGORITHM IDENTIFY SARS-COV-2 VARIANTS BASED ON CONVENTIONAL rRT-PCR? PROOF OF CONCEPTPreprint

Cabrera, J. J., Larrañaga, A., Pérez‐Castro, S., Martínez, J. M., Lamas, L. M., Daviña‐Núñez, C., del Campo-Pérez, V., Luque, S. S., Regueiro, B. J., & Porteiro, J. (2021) · medRxiv · doi:10.1101/2021.11.12.21266286 · Cited by 1

O Contributo da Genómica do SARS-CoV-2 Para a Gestão da Pandemia de COVID-19 em Portugal

Gomes, J. P. (2021) · Acta Médica Portuguesa · doi:10.20344/amp.16505

High diagnostic performance of a novel reverse transcription loop-mediated isothermal amplification (RT-LAMP) kit for the rapid detection of SARS-CoV-2Preprint

Domnich, A., Orsi, A., Panatto, D., Pace, V. D., Ricucci, V., Caligiuri, P., Guarona, G., Chessa, V., Ferone, D., Boccotti, S., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-956125/v1

SARS-CoV-2 variants of concern remain dependent on IFITM2 for efficient replication in human lung cellsPreprint

Nchioua, R., Schundner, A., Kmieć, D., Bozzo, C. P., Zech, F., Koepke, L., Graf, A., Krebs, S., Blum, H., Frick, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.17.468942

Diagnostica molecolare di precisione: un'unica strategia per rilevare SARS-CoV-2 e il lineage B.1.1.7

TRINCHESE, G., MARTINO, M. C. D., & Saraiello, A. (2022) · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · doi:10.23736/s1825-859x.22.00145-1

Ausbreitungsdynamik der Alpha- und Beta-Virusvarianten von SARS-CoV-2 zum Beginn ihres Auftretens in der Stadt Köln im Januar und Februar 2021

Weirich, A., Wiesmueller, G. A., Hurraß, J., & Kossow, A. (2022) · Das Gesundheitswesen · doi:10.1055/a-1967-9855

Observational cohort study of the clinical outcomes associated with B.1.1.7/SGTF among hospitalized COVID-19 patients in Lebanon

Dakroub, F., Yassine, M., Fakhredine, S., Msheik, A., Rahal, H., Hayek, G., Akl, A., Zaarour, R., & Akl, H. (2023) · Eastern Mediterranean Health Journal · doi:10.26719/emhj.23.052

Current Progress in Genomic and Genetic Research on Human Viral Diseases

(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4833-2 · Cited by 1

SARS-CoV-2 Variants and Clinical Implications: A Review Article

Zaputra, D., & Utama, I. M. S. (2024) · International Journal Of Scientific Advances · doi:10.51542/ijscia.v5i2.9

Lessons from Two Early COVID-19 Hospital Outbreaks in Germany to Inform Strategies for Controlling Emerging Nosocomial Outbreaks of Highly Transmissible Respiratory Viruses

Burdi, S., Reichert, F., Mühlemann, B., Corman, V. M., Jones, T. C., Hölzer, M., Schink, S. B., Larscheid, P., Schumacher, J., Widders, G., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15062290

Investigation of SARS-CoV-2 Variants at Primer Binding Sites in Diagnostic Platforms and the Effect on Laboratory Diagnostic SamplesPreprint

Mardani, P., Rahimian, K., Mahmanzar, M., Karimi, M., Saadatpour, F., & Arefian, E. (2026) · Research Square · doi:10.21203/rs.3.rs-8703149/v1

Reliability of Spike Gene Target Failure for ascertaining SARS-CoV-2 lineage B.1.1.7 prevalence in a hospital settingPreprint

Guerra‐Assunção, J. A., Randell, P. A., Boshier, F. A. T., Crone, M. A., Pang, J., Mahungu, T. W., Freemont, P. S., & Breuer, J. (2021) · medRxiv · doi:10.1101/2021.04.12.21255084 · Cited by 8

Monitoring the rise of the SARS-CoV-2 lineage B.1.1.7 in Tenerife (Spain) since mid-December 2020

Alcoba-Flórez, J., Lorenzo-Salazar, J. M., Gil-Campesino, H., Íñigo-Campos, A., de Artola, D. G.-M., García‐Olivares, V., Díez-Gil, O., Valenzuela-Fernández, A., Ciuffreda, L., González‐Montelongo, R., et al. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.04.005 · Cited by 6

S-Gene Target Failure as a Marker of Variant B.1.1.7 Among SARS-CoV-2 Isolates in the Greater Toronto Area, December 2020 to March 2021

Brown, K. A., Gubbay, J. B., Hopkins, J. P., Patel, S. N., Buchan, S. A., Daneman, N., & Goneau, L. W. (2021) · JAMA · doi:10.1001/jama.2021.5607 · Cited by 116

Uncovering Ways That Emerging Severe Acute Respiratory Syndrome Coronavirus 2 Lineages May Increase Transmissibility

Lemieux, J. E., & Li, J. Z. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab083 · Cited by 10

Rapid Spread of the SARS-CoV-2 Variant of Concern 202012/01 in Southern Italy (December 2020–March 2021)

Loconsole, D., Centrone, F., Morcavallo, C., Campanella, S., Sallustio, A., Accogli, M., Fortunato, F., Parisi, A., & Chironna, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18094766 · Cited by 33